CyGenics Ltd signed an agreement with the Blood Centre of Zhejiang Province (ZBC) in China for development work generating human T cells outside the body for the treatment of HIV, using CyGenics' proprietary cellular growth technology. This cellular growth technology is owned by CyGenics' wholly own more
To use all functions of this page, please activate cookies in your browser.
